A new bowel cancer screening test that can be done at home is 94 per cent accurate when compared with colonoscopies and has been submitted to the US Food and Drug Administration (FDA) for approval.

Due to its invasive nature, a concerning number of people are refraining from taking colonoscopies. But an AI-powered alternative may be on the horizon.

The upward trend of colon cancer cases in the U.S. is astronomically high—so much so that in 2021, the U.S. Preventive Services Task Force (USPSTF) updated its recommended age for colorectal cancer ...

The Cologuard Plus test is more accurate than the original Cologuard, and should be easier to mail in for stool analysis. The newest version of Cologuard, an at-home colon cancer screening test, ...

In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved. Access: Patients are 20.29% more likely ...

Researchers have developed a non-invasive stool test that detects colorectal cancer with nearly 90% accuracy by analyzing gut ...

Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening modalities, such as colonoscopy. However, the incidence of colorectal cancer in ...

By applying machine learning to stool samples, they created an inventory, which was then used to detect the presence of ...

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...

NEW YORK, March 13 (UPI) --A blood test to screen for colorectal cancer in average-risk individuals without symptoms accurately detected the malignancy in 83% of people confirmed to have the disease, ...

Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...